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Copyright © 2010 JCBN Summary Dexrazoxane (ICRF-187) has been clinically used to reduce doxorubicin-induced
cardiotoxicity for more than 20 years. It has been proposed that dexrazoxane may act through
its rings-opened hydrolysis product ADR-925, which can either remove iron from the iron-
doxorubicin complex or bind to free iron, thus preventing iron-based oxygen radical forma-
tion. However, it is not known whether the antioxidant actions of dexrazoxane are totally
dependent on its metabolization to its rings-opened hydrolysis product and whether dexrazoxane
has any effect on the iron-independent oxygen free radical production. In this study, we
examined the scavenging effect of dexrazoxane on hydroxyl, superoxide, lipid, DPPH and
ABTS+ free radicals in vitro solution systems. The results demonstrated that dexrazoxane was
an antioxidant that could effectively scavenge these free radicals and the scavenging effects of
dexrazoxane did not require the enzymatic hydrolysis. In addition, dexrazoxane was capable
to inhibit the generation superoxide and hydroxyl radicals in iron free reaction system,
indicating that the antioxidant properties of dexrazoxane were not solely dependent on iron
chelation. Thus the application of dexrazoxane should not be limited to doxorubicin-induced
cardiotoxicity. Instead, as an effective antioxidant that has been clinically proven safe,
dexrazoxane may be used in a broader spectrum of diseases that are known to be benefited
by antioxidant treatments.
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Introduction
Dexrazoxane (ICRF-187; Fig. 1) has been clinically used
to reduce doxorubicin-induced cardiotoxicity for more than
20 years [1–8]. Evidence has indicated that the iron-
dependent oxygen free radical formation on the relatively
unprotected cardiac muscle is a major cause of the cadio-
toxicity induced by doxorubicin [9, 10]. It has been pro-
posed that dexrazoxane can be converted by dihydroorotase
(DHOase) to its rings-opened hydrolysis product ADR-925
(Fig. 1), which can either remove iron from the iron-
doxorubicin complex or bind to free iron, thus preventing
iron-based oxygen radical formation [11–16]. However,
several questions remain unanswered. First, are the anti-
oxidant actions of dexrazoxane totally dependent on its
metabolization to its rings-opened hydrolysis product ADR-
925?  Second, does dexrazoxane have any effect on the iron-
independent oxygen free radical production or it only
scavenges oxygen free radical generated from iron-
dependent process? Elucidation of these questions may help
to evaluate the clinical use of dexrazoxane as an antioxidant
directly in conditions other than doxorubicin-induced
cardiotoxicity.
Here we examined the scavenging effect of dexrazoxane
on hydroxyl, superoxide, lipid, diphenylpicrylhydrazyl
(DPPH) and 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulphonic
acid) (ABTS+) free radicals in vitro reaction solution
systems and found that dexrazoxane effectively scavenged
these free radicals. The results also demonstrated that the
antioxidant actions of dexrazoxane did not require its
enzymatic hydrolysis or solely depend on iron chelation,Dexrazoxane Can Scavenge Free Radicals Directly
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suggesting the potential applications of dexrazoxane in a
broader spectrum of diseases that are known to be benefited




Dexrazoxane was purchased from Najing Aosaikang
Medicinal Group Co. (Nanjing, China). 2,2'-azino-bis (3-
ethylbenzthiazoline-6-sulphonic acid) (ABTS) diammonium
salt, DMPO (5,5-dimethyl-1-pyroline-1-oxide), diphenylpic-
rylhydrazyl (DPPH), TEMP (2,2,6,6-tetramethul-1-piperide),
2-BA-2-DMHB (2-butylamino-2-demethoxyhypocrellin B),
and 4-POBN(-(4-pyridyl-1-oxide)-N-tert-butylnitrone) were
purchased from Sigma Chem Co. (USA). Other agents were
of analytical grade from China.
Scavenging effect of dexrazoxane on ABTS+ free radical
measured by spectrophotometer
A stable stock free radical ABTS+ solution was prepared
the day before the analysis. In brief, 192 mg of ABTS and
33 mg of K2S2O8 were dissolved in a 25 mL volumetric flask
and stored overnight (12–16 h) in the dark at room tempera-
ture. A working ABTS+ solution was prepared on the day of
the analysis, by dilution of the stock ABTS+ solution in
ethanol to reach an absorbance of 1.30 ± 0.05 AU at 734 nm
in a 1 cm cuvette measured with spectrophotometer [17, 18].
Different concentrations of dexrazoxane were added to the
ABTS+ working solution and measured at 734 nm until the
absorption was stable for 5 min.
Scavenging effect of dexrazoxane on free radicals measured
by ESR
To measure free radicals using Electron Spin Resonance
(ESR) spectroscopy, spin trap reagents were added to in vitro
free radical generation systems in the absence or presence of
dexrazoxane following the procedure described previously
[19–21]. The reaction systems for generation of different
free radicals are listed in Table 1. ESR signal intensities
in the absence of or presence of dexrazoxane were recorded
as Ho and Hx, respectively. The scavenging effect was
Fig. 1. a. A reaction scheme for the hydrolysis of dexrazoxane to metabolites B and C and its strong metal ion-chelating form ADR-
925; b. DHOase-catalyzed reversible conversion of L-dihydroorotate into N-carbamoyl-L-aspartate (carbamyl aspartate).Z. Junjing et al.
J. Clin. Biochem. Nutr.
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calculated by [(Ho-Hx)/Ho] × 100%. The ESR measure-
ments were performed using a Brucker ER200 D-SRC ESR
spectrometer (Brucker Analytischem Messtechjik GMBH,
Sibeerstreifen, Germany) with following parameters: X-
band, 100 kHz modulation with amplitude 1 G, microwave
power 10 mW, central magnetic field 3,250 G, sweep width
200 G, temperature 20°C.
Preparation of mitochondria
Male SD rats (223–230 g) were purchased from Institute
of Laboratory Animal Science, Chinese Academy of Medical
Science (Beijing, China). Animal experiments were carried
out in accordance with the NIH Guide for the Care and Use
of Laboratory Animals and were approved by the local
animal care committee. Mitochondria were isolated from
the rat liver following the procedure described previously
with slight modifications [19]. In brief, the liver tissues
were minced, washed and then homogenized at 4°C in 0.9%
NaCl. The homogenate was centrifuged at 600 g for 7 min.
The resulted supernatant was centrifuged again at 10,000 g
for 10 min. Mitochondrial pellets was then washed twice
with a buffer containing 3 mmol/L MgCl2, 50 mmol/L Tris-
HCL (pH 7.5) and 0.2 mmol/L sucrose and resuspended in
the same buffer.
Statistical Analysis
All experiments were repeated six times. One-way
ANOVA was used to estimate the overall significance
followed by post hoc Tukey’s tests corrected for multiple
comparisons [22]. Data are presented as mean ± SEM. A
probability level of 5% (p<0.05) is considered to be
significant.
Results
Scavenging effects of dexrazoxane on superoxide free radical
Superoxide free radicals generated from irradiation of
riboflavin were spin trapped by DMPO and exhibited a
signal with 12 lines peaks (aN = 14.2 G, aHβ = 11.2 G,
aHr = 1.3 G) on ESR spectrum (inset in Fig. 2). Addition of
dexrazoxane to the reaction mixture effectively decreased
the ESR signal generated from superoxide free radicals
(Fig. 2). The IC50 of the scavenging effect of dexrazoxane on
superoxide free radical is about 0.40 mg/mL.
Scavenging effect of dexrazoxane on hydroxyl radicals
generated from photolysis of H2O2
The hydroxyl free radicals were generated from photolysis
of H2O2 (0.1%) and spin trapped by DMPO (0.1 mol/L). The
characteristic ESR spectrum exhibiting 4 peaks with 1:2:2:1
intensity (g = 2.0045, aN =a H = 14.9 G) was obtained (inset
in Fig. 3). Addition of dexrazoxane to the reaction mixture
effectively scavenged the hydroxyl radicals generated from
photolysis of H2O2 (Fig. 3) and the IC50 is about 2.10 mg/mL.
Scavenging effect of dexrazoxane on hydroxyl radicals
generated from Fenton reaction
To compare the scavenging effects of dexrazoxane in the
absence and presence of iron, we next examined the effect of
dexrazoxane on hydroxyl free radicals generated from
Fenton reaction using ESR spectroscopy. As shown in
Fig. 4, dexrazoxane can effectively scavenge hydroxyl
radical generated from Fenton reaction and the IC50 is
about 1.60 mg/mL. It seams from the result that dexrazoxane
is more effective for scavenging hydroxyl radicals which are
generated in the presence of iron, but it is hard to keep the
hydroxyl radical concentration is the same in the two
different generation system, even the same concentration of
H2O2 was used.
Scavenging effect of dexrazoxane on lipid free radicals
Lipid peroxidation has been implicated in many human
diseases. We next studied the scavenging effect of dexra-
zoxane on lipid free radical generated in lipid peroxidation
of mitochondria caused by hydroxyl radical from photolysis
of H2O2. The lipid free radicals were spin trapped by 4-
POBN and exhibited a signal with 6 lines on ESR spectrum
(inset in Fig. 5). Dexrazoxane was added to the mitochondria
before the hydroxyl radical stimulation and the production
of lipid free radicals was measured again. It was found that
dexrazoxane effectively scavenged lipid free radicals and
the IC50 is about 4.35 mg/mL (Fig. 5).
Table 1. Reaction systems for free radical scavenging experiments
Free radicals Reaction systems
DPPH DPPH (10 µM) in ethanol (85%) + different concentrations of sample (reacted time 1 min)
Superoxide DMPO (100 µM) + EDTA (5 mM) + riboflavin (0.3 mM) + different concentrations of sample then 
lighted for 1 min
Hydroxyl (photolysis) H2O2 (0.1%) + photolysis + DMPO + different concentrations of sample
Hydroxyl (Fenton reaction) DMPO + ferrous sulfate (25 mM) + H2O2 (0.1%) + different concentrations of sample
Lipid Mitochondria (20 mg protein/ml) + 0.1 M 4-POBN + different concentrations of sampleDexrazoxane Can Scavenge Free Radicals Directly
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Fig. 2. Scavenging effects of dexrazoxane on superoxide free radicals. Superoxide free radicals were generated from irradiation of ri-
boflavin and spin trapped by DMPO. (The ESR spectrum is shown in the inset). Different concentrations of dexrazoxane were
added to the reaction mixture and the generation of superoxide free radicals was determined by ESR spectroscopy. Details of the
procedure are described in the “Materials and Methods” (n =6 ) .
Fig. 3. Scavenging effects of dexrazoxane on hydroxyl free radicals generated from photolysis of H2O2. The inset shows the ESR
spectrum of hydroxyl free radicals spin trapped by DMPO. Details of the procedure are described in the “Materials and
Methods” (n =6 ) .Z. Junjing et al.
J. Clin. Biochem. Nutr.
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Scavenging effects of dexrazoxane on DPPH free radical
Stable free radical DPPH has been used to estimate the
activity of antioxidants [19]. We examined the scavenging
effect of dexrazoxane on DPPH free radicals using ESR
spectroscopy. The ESR spectrum of DPPH free radical in
ethanol solution is shown in the inset of Fig. 6. Adding
dexrazoxane to the DPPH solution effectively decreased the
intensity of the ESR signal generated from DPPH free
radical and the IC50 is about 3.45 µg/mL (Fig. 6).
Scavenging effects of dexrazoxane on ABTS+
ABTS assay is another method frequently used for
Fig. 4. Scavenging effects of dexrazoxane on hydroxyl free radicals generated from Fenton reaction. The inset shows the ESR
spectrum of DMPO-OH. Details of the procedure are described in the “Materials and Methods” (n =6 ) .
Fig. 5. Scavenging effects of dexrazoxane on lipid free radicals generated from lipid peroxidation of mitochondria. The inset shows the
ESR spectrum of lipid free radicals generated from lipid peroxidation of mitochondria induced by photolysis of H2O2 and spin
trapped by 4-POBN. Details of the procedure are described in the “Materials and Methods” (n =6 ) .Dexrazoxane Can Scavenge Free Radicals Directly
Vol. 47, No. 3, 2010
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measuring antioxidant activities. In the assay, the ABTS+
cation free radical generated by oxidation of ABTS with
potassium persulfate has blue color and absorbs light at
734 nm, which can be reduced by antioxidants and con-
verted to its colorless neutral form. The discolorization is
proportional to the antioxidant activity and can be monitored
by spectrophotometer [17, 18]. As shown in Fig. 7, dexra-
zoxane effectively scavenged ABTS+ cation free radical and
the IC50 is about 3.75 mg/mL.
Fig. 6. Scavenging effects dexrazoxane on DPPH free radical. The inset shows the ESR spectrum of DPPH free radicals. Different
concentrations of dexrazoxane were added to the DPPH free radical solution and analysed by ESR spectroscopy. Details of the
procedure are described in the “Materials and Methods” (n =6 ) .
Fig. 7. Scavenging effects of dexrazoxane on ABTS+ cation free radical. Different concentrations of dexrazoxane were added to the
ABTS+ working solution and measured at 734 nm by spectrophotometer. Details of the procedure are described in the
“Materials and Methods” (n =6 ) .Z. Junjing et al.
J. Clin. Biochem. Nutr.
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Discussion
These results demonstrated that dexrazoxane was an
antioxidant that could effectively scavenge superoxide,
hydroxyl, lipid, DPPH and ABTS+ free radicals in vitro
reaction systems. It was found that dexrazoxane not only
scavenged hydroxyl radical generated from Fenton reaction,
but also effectively inhibited the generation of superoxide,
hydroxyl radicals, lipid, DPPH and ABTS+ in iron free
reaction system, suggesting that iron chelation may be a
factor contributing to the prevention of dexrazoxane on iron-
based free radical generation, however, the antioxidant
properties of dexrazoxane were not solely dependent on
iron chelation. Furthermore, dexrazoxane directly scavenged
oxygen free radicals in the in vitro solution system,
suggesting that the scavenging effects of dexrazoxane did
not require its enzymatic hydrolysis to its ring-opened
forms. This is the first report that the antioxidant activity of
dexrazoxane is not relied on its enzymatic conversion to its
ring-opened hydrolysis products and dexrazoxane is effec-
tive in reducing oxygen free radicals generated from iron-
independent processes. Therefore, dexrazoxane may be
useful clinically for other diseases that are known to be
benefited by antioxidant treatments [23–32] in addition
to doxorubicin-induced cardiotoxicity. The application of
dexrazoxane in those diseases should be evaluated in the
future.
Vitamin C and E are water and lipid soluble vitamins and
they can scavenge water and lipid soluble free radicals
respectively. They can synergically inhibit lipid peroxida-
tion of cell membrane, however, nether vitamin C or vitamin
E alone can not inhibit lipid peroxidation [33]. Dexrazoxane
can scavenge both water and lipid soluble free radicals and it
may be used as combination of vitamin E and E in the future.
Free radicals are normal metabolites in biological systems
and play important role in a variety of physiological func-
tions including immunity, oxidative stress characterized by
an imbalance between the production of reactive oxygen
species and antioxidant defenses has been implicated in
the pathogenesis of many human diseases such as cardio-
vascular diseases, cancer, neurodegenerative diseases. Free
radicals such as Nitric Oxide (NO), hydroxyl, superoxide
and lipid free radicals have closed relation with human
health [23–26]. Free radicals have important biological
functions such as oxygen free radicals in mitochondrial
electron transfer chain, cell growth and differentiation,
immunological response, NO free radical in blood vascular
relaxation, blood pressure modulation, study and memory.
But free radicals also have close relation with most of human
diseases, such as heart and brain vascular diseases, cancers,
aging and neurodegenerative diseases [23–32]. The genera-
tion and scavenging of free radicals or oxidation and reduc-
tion in human body should be balance for human health. If
free radical generation is more than the scavenging, there
will be extra free radicals able to damage cell components
and lead to diseases. If antioxidants were supplied to help
body to keep the balance, the diseases can be prevented.
Dexrazoxane can scavenge free radicals alone suggests that
it can be used as an antioxidant in all these kinds of diseases
and open an new window to use dexrazoxane in clinical
without need to do many pre-clinical experiments because it
has been clinically used as a drug for more than 20 years.
In this paper, we studied the antioxidant activity of
dexrazoxane by examining its scavenging effect on super-
oxide, hydroxyl, lipid, DPPH and ABTS+ free radicals in
in vitro reaction systems. The results showed that the
scavenging effects of dexrazoxane on free radicals do not
require its enzymatic hydrolysis. Furthermore, dexrazoxane
was capable to inhibit the oxygen free radical generation in
iron free reaction system, although iron chelation may be a
factor contributing to the its decrease on iron-based free
radical generation. These results suggest that the antioxidant
properties of dexrazoxane are not solely dependent on iron
chelation. Thus the application of dexrazoxane should not be
limited to doxorubicin-induced cardiotoxicity. Instead, as an
effective antioxidant that has been clinically proven safe,
dexrazoxane may be used in a broader spectrum of diseases
that are known to be benefited by antioxidant treatments.
Conclusion
In this paper, we showed that the scavenging effects of
dexrazoxane on free radicals do not require its enzymatic
hydrolysis and dexrazoxane was capable to inhibit the oxygen
free radical generation in iron free reaction system. Thus
the application of dexrazoxane should not be limited to
doxorubicin-induced cardiotoxicity and, dexrazoxane may
be used in a broader spectrum of diseases that are known to
be benefited by antioxidant treatments.
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